NEWS DETAIL

Disposal of Own Shares

In accordance with article 8:6 of the Royal Decree executing the Belgian Code of Companies and Associations, UCB announces that, following exercises of stock options by members of its personnel, it has disposed of UCB shares OTC in view of deliveries of these shares to the relevant members of the personnel, within the framework of the Long-Term Incentive Program of the UCB Group, as follows:






























































Date of transaction



Time



LTI Plan



Number of disposed UCB shares



Price



03



May



2022



17:06:33



Stock



Option Plan 2013



100





48,69



06



May



2022



09:25:42



Stock



Option Plan 2013



200





48,69



11



May



2022



10:59:58



Stock



Option Plan 2013



100





48,69



11



May



2022



13:53:01



Stock



Option Plan 2013



100





48,69



11



May



2022



15:38:28



Stock



Option Plan 2013



1.000





48,69



12



May



2022



17:07:46



Stock



Option Plan 2013



200





48,69


In addition to these exercises, on 6 May 2022, in accordance with the vesting rules under its 2019 and 2021 LTI plans, UCB SA/NV has delivered for free a total of 481 UCB shares OTC to 4 members of the personnel of the Company and its subsidiaries. The highest independent bid price on Euronext Brussels on 6 May 2022 was € 104.20.


This press release is available on UCB SA/NV’s website via the following link.


For further information, contact UCB:


 


Investor Relations


Antje Witte


T 32 2 559 94 14


[email protected]


Corporate Communications


Laurent Schots T 32 2 559 92 64


[email protected]


About UCB


UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 8 600 people in nearly 40 countries, the company generated revenue of € 5.8 billion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news